Dr. Reddy's Laboratories

April 07, 2020

Biopharma acquisitions slow, but it's not Covid-19's fault yet

Drug makers struck few M&A deals in the first quarter, but activity did not dry up, suggesting that the real impact of coronavirus has yet to play out.

March 31, 2020

Amarin falls at obvious hurdle

Amarin’s loss of a crucial patent lawsuit shows that potential buyers were right to be wary of the Vascepa opportunity.

November 05, 2019

Vascepa's future could hinge on next week's panel

Amarin’s Vascepa is widely expected to receive approval in a huge new patient population. So why has the company not been bought?

May 14, 2019

Price fixing case caps a terrible week for generics

Shares in generics firms tumble in the wake of a huge lawsuit in the US alleging industry-wide price fixing, signalling many more years of pain for this sector.